Mumbai: Cadila Healthcare, the Zydus Cadilla Group flagship, has emerged as the frontrunner to acquire the generic sterile injectables business of Ahmedabad-headquartered Claris Lifesciences Ltd (CLL) trumping several domestic and global peers who ... India Brand Equity Foundation, 2 hours ago
Cadila Healthcare eyes Claris arm for Rs 3,400 crore - Economic Times, 1 day ago
Buy Cadila Healthcare; tgt of Rs 1920: Firstcall Research - Moneycontrol.com, 1 day ago
2 images for "zydus group cadila healthcare"
Related to : Zydus Wellness Ltd,Cadila Healthcare Ltd Zydus Wellness Ltd BSE 15 May 15 | 03:34 PM 970.00 -30.9 (-3.09%) NSE 15 May 15 | 03:40 PM 971.20 -29.15 (-2.91%) Ahmedabad-based drug major Cadila Healthcare Ltd, has posted ...Smart Investor, 6 days ago Cadila Healthcare consolidated net surges by 46% in Q4, dividend at 240% PharmaBiz, 1 week ago Zydus Cadila Q4 net profit up 46% Livemint.com, 6 days ago Cadila Healthcare launches Hepatitis C drug SoviHep Odisha Samaya, 2 months ago
The company said that the medicine will be marketed by the speciality division of the group, Zydus Heptiza. New Delhi: Drug firm Zydus Cadila on Tuesday launched a generic version of Gilead Sciences hepatitis C drug Sofosbuvir in India under the ...Livemint.com, 2 months ago Zydus Cadila Launches Generic Version of Gilead Sciences Hepatitis C drug in India Topnews.in, 2 months ago
Zydus Group to Donate USD 240,000 to The National Institutes of Health, USA for Advancing Leishmaniasis Research
/PRNewswire/ -- Etna Biotech, the Vaccine R & D subsidiary of Zydus, announced a collaborative program with the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health, for advancing leishmaniasis ...Wall Street Business Network, 4 weeks ago
SENSEX 27802.00 35.21 0.13% NIFTY 8408.10 15.15 0.18% Industries: Airlines/Aviation, Metal and Mining, ...Finalaya.com, 1 day ago
New Delhi : Cadila Healthcare Ltd plans to seek "an enabling approval" from its shareholders to raise up to Rs 10,000 crore via issue of different securities. The company's board, which met on Wednesday, decided to seek shareholders' nod to issue ...NDTV Profit, 1 month ago Cadila to seek shareholders' nod to raise up to Rs 10,000 crore Jagran Post, 1 month ago
Cadila Healthcare gains on announcing a collaborative program with the National Institute of Alle...
Cadila Healthcare is currently trading at Rs. 1755.80, up by 7.35 points or 0.42 % from its previous closing of Rs. 1748.45 on the BSE. The scrip opened at Rs. 1770.00 and has touched a high and low of Rs. 1770.00 and Rs. 1742.20 respectively. So ...Arihant Capital, 4 weeks ago Cadila Healthcare gains on inking non-exclusive licensing pact with Gilead Sciences Arihant Capital, 2 months ago Zydus Cadila, Gilead Sciences ink non-exclusive licensing pact Indian-Commodity, 2 months ago
Pharmaceuticals major Zydus today said that its R&D subsidiary Etna Biotech will collaborate with US-based National Institute of Allergy and Infectious Diseases (NIAD) to develop a vaccine against visceral leishmaniasis (VL), known as Kala-Azar in ...Hindu Business Line, 4 weeks ago Zydus ties up with US-based research centre to develop vaccine Daily Excelsior.com, 4 weeks ago Zydus ties up with US-based RD centre to develop vaccine Moneycontrol.com, 4 weeks ago
News Top News Top Story India Infoline News Service | Mumbai | March 18, 2015 09:36 IST New drug launch by Zydus group boosts sentiment at the counter. Cadila Healthcare spurted ...India Infoline, 2 months ago
Pieris Pharmaceuticals to Present Data on Novel Anti-CD137 and HER2 Bispecific Immuno-Oncology Program at UBS Global Healthcare Conference
) - Pieris Pharmaceuticals, Inc . ( OTCQB: PIRS ), a biotechnology company advancing its proprietary Anticalin ® biotherapeutic technologies, announced today that President and CEO, Stephen Yoder, will present preclinical data on a new ...RCL Advisors, 2 days ago PIERIS PHARMACEUTICALS : to Present Data on Novel Anti-CD137 and HER2 Bispecific Immuno-Oncology Program at UBS Global Healthcare Conference 4 Traders, 2 days ago Pieris Pharmaceuticals, Inc. (PIRS: OTCQB) | Pieris Pharmaceuticals to Present at the 2015 UBS Global Healthcare Conference on May 19th, 2015 OTC Markets, 2 weeks ago Pieris Pharmaceuticals to Present at the 2015 UBS Global Healthcare Conference on May 19th, 2015 MoneyShow.com, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!